Bioequivalence data analysis for the case of separate hospitalization

Area of Science:

• Pharmacokinetics and Drug Development
• Biostatistics
• Clinical Trial Design

Background:

• Bioequivalence studies typically involve same-day drug administration.
• Separated hospitalization for bioequivalence studies can occur due to logistical or recruitment challenges.
• Existing analysis methods may not adequately handle data from separated hospitalizations.

Purpose of the Study:

• To propose an improved statistical method for analyzing bioequivalence data when hospitalization is separated.
• To address challenges in subject recruitment leading to separate hospitalizations.
• To enhance the accuracy and reliability of bioequivalence study results in non-standard scenarios.

Main Methods:

• Treating hospitalization date as a random effect instead of a fixed effect.
• Utilizing the PROC MIXED procedure for data analysis.
• Incorporating methods to handle incomplete subject data effectively.

Main Results:

• The proposed method accounts for the variability introduced by separate hospitalizations.
• Using PROC MIXED allows for the inclusion of subjects with incomplete data, which is common in separated hospitalization designs.
• This approach provides a more robust analysis compared to traditional methods like PROC GLM.

Conclusions:

• Considering hospitalization date as a random effect is crucial for accurate bioequivalence analysis with separated hospitalizations.
• PROC MIXED offers a flexible and powerful tool for handling complex bioequivalence data, including incomplete datasets.
• The suggested methodology enhances the validity of bioequivalence findings when study logistics necessitate separated hospitalizations.